NG2-expressing glial precursor cells are a new potential oligodendroglioma cell initiating population in N-ethyl-N-nitrosourea-induced gliomagenesis.

Carcinogenesis
Anne Briançon-MarjolletJacques Baudier

Abstract

Gliomas are the most common primary brain tumor affecting human adults and remain a therapeutic challenge because cells of origin are still unknown. Here, we investigated the cellular origin of low-grade gliomas in a rat model based on transplacental exposure to N-ethyl-N-nitrosourea (ENU). Longitudinal magnetic resonance imaging coupled to immunohistological and immunocytochemical analyses were used to further characterize low-grade rat gliomas at different stages of evolution. We showed that early low-grade gliomas have characteristics of oligodendroglioma-like tumors and exclusively contain NG2-expressing slow dividing precursor cells, which express early markers of oligodendroglial lineage. These tumor-derived precursors failed to fully differentiate into oligodendrocytes and exhibited multipotential abilities in vitro. Moreover, a few glioma NG2+ cells are resistant to radiotherapy and may be responsible for tumor recurrence, frequently observed in humans. Overall, these findings suggest that transformed multipotent NG2 glial precursor cell may be a potential cell of origin in the genesis of rat ENU-induced oligodendroglioma-like tumors. This work may open up new perspectives for understanding biology of human gliomas.

References

Jan 1, 1995·Journal of Neuropathology and Experimental Neurology·J A KrausA von Deimling
Aug 10, 1999·Journal of Neuroscience Research·S W LevisonJ E Goldman
Sep 1, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y ShoshanS M Staugaitis
Aug 24, 2000·Journal of Neuroscience Research·M R DawsonR Reynolds
Nov 23, 2001·Journal of Neuro-oncology·H Ding, A Guha
Nov 28, 2001·Current Opinion in Neurology·J R Perry
Oct 24, 2003·Molecular and Cellular Neurosciences·Mary R L DawsonRichard Reynolds
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Houman D HemmatiHarley I Kornblum
Jan 20, 2004·Acta Neuropathologica·Markus J RiemenschneiderGuido Reifenberger
May 26, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·William SlikkerTao Chen
Nov 19, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Adan Aguirre, Vittorio Gallo
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Jun 22, 2005·Current Treatment Options in Neurology·Warren P Mason
Aug 9, 2005·Developmental Biology·Lamia Bouslama-OueghlaniIsabelle Dusart
Oct 6, 2005·Journal of Neuro-oncology·Sergei I BannykhMichael Wegner
Jun 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Marcela AssanahPeter Canoll
Sep 20, 2006·Cancer Research·Laurent BalenciJacques Baudier
Dec 6, 2006·Journal of Neuropathology and Experimental Neurology·Hiroko OhgakiFrank L Heppner
Apr 27, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Laurent BalenciJacques Baudier
Sep 21, 2007·Nature Reviews. Cancer·Richard J Gilbertson, Jeremy N Rich
Apr 11, 2008·Journal of Molecular Neuroscience : MN·Michael Wegner
Oct 14, 2008·Nature Neuroscience·Leanne E RiversWilliam D Richardson
Nov 10, 2009·Expert Review of Anticancer Therapy·Zarnie LwinWarren P Mason

❮ Previous
Next ❯

Citations

Sep 4, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Kaustuv BasuSamaresh Chaudhuri
Sep 13, 2011·Cancer Cell·Sista SugiartoClaudia Petritsch
Jan 12, 2017·Acta Neuropathologica·Krissie LentingWilliam Leenders
Sep 26, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Alexandra Y TsidulkoElvira V Grigorieva
Sep 15, 2018·International Journal of Molecular Sciences·Davide SchifferLaura Annovazzi
Jun 2, 2018·Veterinary Pathology·Takuya E KishimotoHiroyuki Nakayama
Nov 26, 2013·Molecular Cancer Research : MCR·Maya SrikanthJohn A Kessler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.